CVA Family Office’s Protolabs PRLB Stock Holding History

CVA Family Office’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7	Closed	-$1K	–	756
2021 Q2	$1K	Buy	+7	New	+$690	﹤0.01%	924

Other funds holding PRLB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CVA Family Office's PRLB Position: Q3 2021 in Review

CVA Family Office sold out of Protolabs (PRLB) in Q3 2021, closing a stake of 7 shares — an estimated $1K sold.

CVA Family Office first reported a position in PRLB in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 263 funds tracked by Wall St. Rank hold PRLB as of Q3 2021.

CVA Family Office reported no remaining Protolabs position as of Q3 2021 after selling out during the quarter.
CVA Family Office sold 7 Protolabs shares in Q3 2021, an estimated $1K.
CVA Family Office first reported a position in Protolabs in Q2 2021 and held it in 1 quarter.
CVA Family Office's Protolabs position peaked at $1K in Q2 2021.
263 funds tracked by Wall St. Rank held Protolabs as of Q3 2021.

Based on CVA Family Office's 13F filing for Q3 2021, filed 12 Oct 2021.